The role of cytokines in the development of systemic inflammation in chronic obstructive pulmonary disease and obesity

The role of cytokines in the development of systemic inflammation in chronic obstructive pulmonary disease and obesity

Patients with chronic obstructive pulmonary disease (COPD) are characterized by a variety of comorbid conditions, including both somatic (arterial hypertension, atherosclerosis, coronary heart disease, bronchial asthma, malignant neoplasms, diabetes mellitus, obesity, etc.) and mental (depressive d...

Full description

Bibliographic Details
Main Authors:	A. Yu. Blagov, O. A. Efremova, E. M. Khodosh, K. S. Aleinikova, V. A. Dubrova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2023-04-01
Series:	Ожирение и метаболизм
Subjects:	cytokines inflammation chronic obstructive pulmonary disease interleukin-6 obesity comorbidity
Online Access:	https://www.omet-endojournals.ru/jour/article/view/12847

Similar Items

Proinflammatory cytokines in patients with acute myocardial infarction against the background of chronic obstructive pulmonary disease
by: A. V. Naumov, et al.
Published: (2020-09-01)

THE ROLE OF SOME INFLAMMATORY CYTOKINES IN THE DEVELOPMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE BACKGROUND OF OBESITY
by: L. V. Savchenko, et al.
Published: (2017-03-01)

Comorbidity of chronic heart failure and chronic obstructive pulmonary disease: features of pathogenesis, clinic and diagnostics
by: R. E. Tokmachev, et al.
Published: (2018-12-01)

Chronic obstructive pulmonary disease and type 2 diabetes mellitus – diseases with cytokine imbalance
by: L. N. Sorokina, et al.
Published: (2024-10-01)

Eﬀect of the combination of theophylline and budesonide on production of proinﬂammatory cytokines by blood cells of patients with chronic obstructive pulmonary disease
by: A. G. Kadushkin, et al.
Published: (2021-11-01)

Influence of inflammatory cytokines on the course of chronic obstructive pulmonary disease
by: L.B. Vynnychenko, et al.
Published: (2021-02-01)

Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis
by: Jia Wei, et al.
Published: (2015-08-01)

Systemic cytokine potential in patients with chronic obstructive pulmonary disease who completed treatment for pulmonary tuberculosis
by: A. A. Khrenov, et al.
Published: (2020-02-01)

EFFECTIVENESS OF THE PULMONARY REHABILITATION PROGRAMME IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND OBESITY
by: Evgeny S. Ovsyannikov, et al.
Published: (2019-07-01)

Systemic inflammation and complications of”vascular" comorbidity in patients with COPD
by: A. S. Skotnikov, et al.
Published: (2015-10-01)

Dependence of cytokinemia on the clinical course of chronic obstructive pulmonary disease combined with hypertension.
by: V.A A. Kapustnyk, et al.
Published: (2018-11-01)

ROLE OF IL-4, IL-6, IL-8, IL-10 CYTOKINES IN THE IMMUNOPATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. Yu. Trushina, et al.
Published: (2019-01-01)

Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease
by: Priti Lokesh Meshram, et al.
Published: (2018-01-01)

Comorbidity in chronic obstructive pulmonary disease patient
by: Leonid I. Dvoretsky
Published: (2023-08-01)

Role of comorbidities in acquiring pulmonary fungal infection in chronic obstructive pulmonary disease patients
by: Ashraf Z. Mohamed, et al.
Published: (2016-11-01)

The Kynurenine Pathway in Healthy Subjects and Subjects with Obesity, Depression and Chronic Obstructive Pulmonary Disease
by: Per G. Farup, et al.
Published: (2023-02-01)

ROLE OF SYSTEMATIC INFLAMMATION IN THE DEVELOPMENT OF COMORBIDITY IN CASE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: V. A. Nikitin, et al.
Published: (2017-06-01)

Involvement of Gas6 protein in mouse model of lipopolysaccharide-induced lung inflammation
by: William R Surin, et al.
Published: (2018-01-01)

EVALUATION OF CYTOKINE-MEDIATED MECHANISMS INVOLVED IN DEVELOPMENT OF RESPIRATORY MUSCLE DYSFUNCTION IN THE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. P. Kalinina, et al.
Published: (2019-07-01)

Effect of toxic air pollutants on the cytokine release by leukocytes in patients with chronic obstructive pulmonary disease
by: A. U. Ishchanka
Published: (2022-12-01)

The processes of inflammation and fibrosis in patients with chronic obstructive pulmonary disease
by: T.A. Pertseva, et al.
Published: (2020-12-01)

Cardiac abnormalities in stable chronic obstructive pulmonary disease: correlations and predictors
by: Hend Ismael, et al.
Published: (2023-01-01)

COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS
by: N. A. Karoli, et al.
Published: (2016-01-01)

EVALUATION OF CYTOKINE-MEDIATED MECHANISMS INVOLVED IN DEVELOPMENT OF RESPIRATORY MUSCLE DYSFUNCTION IN THE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: Elena Kalinina, et al.
Published: (2019-03-01)

Pulmonary dysfunction in overweight and obese children with obstructive sleep apnoea
by: Aina Salwa Kasim, et al.
Published: (2023-05-01)

Assessment of association between interleukin 6 gene variant and its serum level in chronic obstructive pulmonary disease in a sample of Egyptian population
by: Hala Ashraf, et al.
Published: (2024-01-01)

Association of comorbid anxiety and depression with chronic obstructive pulmonary disease
by: Ruchi Dua, et al.
Published: (2018-01-01)

CYTOKINE PROFILE FEATURES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. Р. Kalinina, et al.
Published: (2014-07-01)

Effect of combined exercise and N-acetylcysteine supplementation on inflammatory markers in patients with chronic obstructive pulmonary disease
by: Amirreza Ebrahimi, et al.
Published: (2024-10-01)

Chronic Obstructive Pulmonary Disease as a Cardiovascular Diseases Risk Factor in Erbil
by: Goran Abubaker Osman, et al.
Published: (2019-11-01)

Chronic obstructive pulmonary disease and heart failure: research and clinical practice in primary care
by: Francesco Chiumeo, et al.
Published: (2015-12-01)

Assessment of cognitive dysfunction, depression, and anxiety in patients with stable chronic obstructive pulmonary disease in relation to serum interleukin-6
by: Samah M Shehata, et al.
Published: (2018-01-01)

Depressive disorders in patients with chronic obstructive pulmonary disease with comorbid course with metabolic syndrome
by: Evgeny V. Kozlov, et al.
Published: (2023-07-01)

Trial of atorvastatin on serum interleukin-6, total antioxidant capacity, C-reactive protein, and alpha-1 antitrypsin in patients with chronic obstructive pulmonary disease
by: Anahita Arian, et al.
Published: (2018-01-01)

A study to determine systemic anti-inflammatory mediators in chronic obstructive pulmonary disorder
by: Nikhil Sinha, et al.
Published: (2023-11-01)

Clinical and Anamnestic Features of Patients with Ischemic Heart Disease and Chronic Obstructive Pulmonary Disease
by: Oybek Urinov, et al.
Published: (2025-03-01)

Comparing chronic obstructive pulmonary disease and depressive disorder in terms of inflammation-related biomarkers
by: Elżbieta Małujło-Balcerska, et al.
Published: (2023-05-01)

Comorbidity among Hospitalized Patients with Chronic Obstructive Pulmonary Disease in a Teaching Hospital, West Java Indonesia
by: Dini Qurrotu Aini, et al.
Published: (2015-12-01)

Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review
by: Xiang Y, et al.
Published: (2024-02-01)

Clinical Diagnostic Value of Serum GABA, NE, ET-1, and VEGF in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension
by: Yan J, et al.
Published: (2023-08-01)